Latest news:

BioStock article: Follicum applies for extended patent for its topical formulation

BioStock published an article on 12 May 2020 about Follicum, which can be read in full below. The peptide specialist company Follicum has filed an international patent application for its topical cream formulation. The application is both relevant for the company’s furthest-advanced candidate, FOL-005, which is currently undergoing a clinical phase IIa study in hair […]

Sign up for our Newsletter

Follicum’s compliance with GDPR. Read more

Follicum's presentation at LSX World Congress 2020

Hair growth

Our drug candidate FOL-005 has demonstrated increased hair growth on both healthy individuals and on patients with alopecia in two clinical phase II trials, which both demonstrated good safety and efficacy.

Read more


Follicums pre-clinical research has resulted in a new peptide class which increased the release of insulin on mice

Read more


We want to develop safe, effective and cost effective drugs, suitable for both men and women, that have minimal side effects

Read more




18 Jun 20
Diabetes webinar

Jan Alenfall will participate in the webinar “Connecting the R&D of auto-immune disease th...

26 Oct 20

Follicum will attend the BIO-Europe conference in Munich, Germany, on 26-28 October 2020 The confere...